Biotechnology News

April 18, 2014

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. invites investors and the general public to listen to a webcast of the Annual Meeting of Shareholders at 8:30 a.m. (Eastern Daylight Time) on Thursday, April 24. To access the webcast, visit our website at...

April 18, 2014

LEXINGTON, Mass.--(BUSINESS WIRE)--Cubist Pharmaceuticals Issues Voluntary Nationwide Recall of One Lot of CUBICIN (daptomycin for injection) 500 mg in 10 mL single use vials
Due to Presence of Particulate Matter

April 18, 2014

WASHINGTON--(BUSINESS WIRE)--Pioneers in Regenerative Therapy to Discuss New Trends in Stem Cell Medicine; International leaders to share unparalleled achievements in stem cell research at DIA Annual Meeting

April 18, 2014

GEORGETOWN, Texas--(BUSINESS WIRE)--Molecular Templates, Inc., a biopharmaceutical company focused on the discovery and development of a new class of biologic therapies announced today that it presented preclinical data in two poster...

April 18, 2014

ROCKVILLE, Md.--(BUSINESS WIRE)--Tech Council of Maryland hosts Maryland gubernatorial candidates in forum to discuss issues impacting tech and life sciences sectors in the state.

April 18, 2014

SAN DIEGO--(BUSINESS WIRE)--Bioserv Corporation, a contract manufacturer of injectable pharmaceuticals and medical devices, is pleased to announce the appointment of Jay Schrier, Ph.D., as Senior Vice President of Pharmaceutical Technologies. Dr...

April 17, 2014

--(BUSINESS WIRE)--Vince & Associates Clinical Research:                   Who: Guest of Honor - Overland Park, KS Mayor, Carl Gerlach   What: Vince & Associates Clinical Research will host a ceremony to mark the groundbreaking of the new...

April 17, 2014

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck today announced that the U.S. Food and Drug Administration has approved RAGWITEK™ (Short Ragweed Pollen Allergen Extract) Tablet for Sublingual Use (12 Amb a 1-U).

April 17, 2014

DUBLIN, Ohio--(BUSINESS WIRE)--Navidea provided updates on several programs and events relating to Lymphoseek including a head-to-head clinical study underway at the UCSD.

April 17, 2014

WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops novel anticancer therapeutics using its antibody-drug conjugate (ADC) technology, today announced that the Company will host a conference call...

April 17, 2014

CHESHIRE, Conn.--(BUSINESS WIRE)--Alexion announced the appointment of John “Jack” T. Mollen to its Board of Directors. The Company also announced that Joseph A. Madri, Ph.D., M.D. and Larry L. Mathis, will retire on May 5, 2014.

April 17, 2014

NEEDHAM, Mass.--(BUSINESS WIRE)--Bio-IT World announced that its 13th annual conference and expo, to be held April 29-May 1 at the Seaport World Trade Center in Boston, will debut a new disciplinary track focused on Data Security.

April 17, 2014

NEEDHAM, Mass.--(BUSINESS WIRE)--Medical Informatics World Conference announced it will debut a new disciplinary track focused on information security and privacy in healthcare.

April 17, 2014

WASHINGTON--(BUSINESS WIRE)--Innovative Blue Button Project to Be Discussed at DIA 2014 50th Annual Meeting; Session will explore state-of-the-art initiative allowing patients to access their individual data

April 17, 2014

PARIS--(BUSINESS WIRE)--Regulatory News: Mauna Kea Technologies (Paris:MKEA) (Euronext: MKEA, FR0010609263), leader in the Optical Biopsy market, announced today major progress in the adoption of Optical Biopsy around the world. While more than...

April 17, 2014

EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE MKT: NBY), a clinical-stage biopharmaceutical company, today announced that WoundSource™ has highlighted NovaBay’s NeutroPhase wound cleanser in a recent blog posting. The...

April 17, 2014

MIAMI--(BUSINESS WIRE)--OPKO Health, Inc. (NYSE:OPK) has entered into a definitive agreement to acquire Inspiro Medical Ltd. (“Inspiro”), an Israeli medical device company developing a new platform to deliver small molecule drugs such as...

April 17, 2014

WASHINGTON--(BUSINESS WIRE)--DIA 2014 50th Annual Meeting to Examine the Changing Landscape for Bioinnovation; Industry experts to discuss the emergence of small pharma, strategic alliances and precision medicine

April 17, 2014

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that Joshua Rabinowitz, M.D., Ph.D., professor at Princeton University’s Department of Chemistry and the Lewis-Sigler Institute for Integrative Genomics,...

April 17, 2014

MORRISTOWN, N.J.--(BUSINESS WIRE)--Pernix Therapeutics Holdings, Inc. (“Pernix” or the “Company”) (NASDAQ MKT: PTX), a specialty pharmaceutical company, today announced it has signed a lease for new corporate headquarters at 10 North Park Place...

April 17, 2014

PARIS--(BUSINESS WIRE)--France Biotech (www.france-biotech.org), an association of Entrepreneurs in Life Sciences announces the first edition of "French Life Sciences Days...

April 17, 2014

WESTMINSTER, Colo.--(BUSINESS WIRE)--ARCA announces the first patient has been genetically screened in GENETIC-AF, its Phase 2B/3 clinical trial that will evaluate Gencaro as a potential genetically targeted treatment for A-fib.

April 17, 2014

SALEM, N.H.--(BUSINESS WIRE)--Gamma Medica Creates Strategic Advisory Board Chaired by Veteran Health Technology Executive Robert Cascella

April 17, 2014

BURLINGTON, Mass.--(BUSINESS WIRE)--Dyax Corp. (NASDAQ:DYAX) will host a webcast and conference call, including an open question and answer session, Wednesday, April 30, 2014. During the call, management will discuss the Company’s financial...

April 17, 2014

NEW YORK--(BUSINESS WIRE)--Zocere received the Top Innovator Award by Young Startup Ventures at the 2014 Life Sciences & Venture Summit. April 2 in NYC. Zocere is developing a neuroprotectant drug for stroke and brain trauma.

April 17, 2014

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Quintiles recognized for its service quality in Phase ll/lll research by Industry Standard Research.

April 17, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a leader in the fields of cancer metabolism and inborn errors of metabolism (IEM), today announced dose administration of AG-348 in a Phase 1 study in healthy...

April 17, 2014

KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Theorem Clinical Research, a leading contract research organization that optimizes trial conduct, recently expanded its Medidata partnership by obtaining accreditation for Medidata Patient Cloud™.

April 17, 2014

NEWTON, Mass.--(BUSINESS WIRE)--Alcresta®, a leading medical nutrition company developing innovative enzyme-based products for individuals with unique nutritional needs battling acute conditions or chronic diseases, today announced the company...

April 17, 2014

BEDFORD, Nova Scotia--(BUSINESS WIRE)--The Nova Scotia College of Medical Laboratory Technologists is proud to be celebrating National Medical Laboratory Week from April 20th – 26th. As the fourth largest health care profession, this group is...

April 17, 2014

ROCKVILLE, Md.--(BUSINESS WIRE)--Emergent BioSolutions plans to participate in the Mizuho, Bank of America Merrill Lynch and UBS investor conferences in May 2014.

April 17, 2014

EWING, N.J.--(BUSINESS WIRE)--Antares Pharma, Inc. (NASDAQ: ATRS) today announced that the Annals of the Rheumatic Diseases has published results from an open-label, head-to-head randomized, crossover study comparing the relative bioavailability...

April 17, 2014

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX) today reported first quarter financial results that exceeded the company’s previously issued guidance and confirmed its full-year 2014 financial outlook. For the first quarter...

April 17, 2014

PARSIPPANY, N.J.--(BUSINESS WIRE)--Pacira Pharmaceuticals Announces Timing for First Quarter 2014 Financial Results Webcast and Conference Call

April 17, 2014

LOS ANGELES--(BUSINESS WIRE)--Targeted Medical Pharma (OTCQB:TRGM) finalizes a distribution contract for twenty countries in the Middle East, providing the company with a platform for international growth.

April 17, 2014

INGELHEIM, Germany--(BUSINESS WIRE)--For media outside of the US and UK only Boehringer Ingelheim announced today that the US Food and Drug Administration (FDA) and the European Commission have granted volasertib* ‘orphan drug designation’ for...

April 17, 2014

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: NeuroVive (STO:NVP), a leading mitochondrial medicine company, is presenting a breakthrough in the company’s work on energy regulation at the cellular level. Based on the UK company Selcia Ltd’s...

April 16, 2014

BEDFORD, Mass--(BUSINESS WIRE)--Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced that it plans to issue its first-quarter 2014 financial results after the close of the market on Tuesday, April 29, 2014. The company plans to hold a...

April 16, 2014

WATERTOWN, Mass.--(BUSINESS WIRE)--Dicerna Pharmaceuticals, Inc. (NASDAQ: DRNA), a leader in the development of RNAi-based therapeutics, today announced the initiation of a Phase 1 dose-escalating clinical study of DCR-MYC, (also known as DCR-...

April 16, 2014

MURRAY HILL, N.J.--(BUSINESS WIRE)--The Board of Directors of C. R. Bard, Inc. (NYSE:BCR) today declared a regular quarterly dividend of 21 cents per share on Bard's common stock. The current indicated annual dividend rate is 84 cents per share....

April 16, 2014

LEXINGTON, Mass.--(BUSINESS WIRE)--Agenus Inc. (NASDAQ: AGEN) invites investors and the general public to its Annual Meeting of Stockholders to begin at 5:00 p.m. ET on Wednesday, April 23, 2014. The meeting will be held at the company's...

April 16, 2014

WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (the “Company”) (Nasdaq: NURO), an innovative health care company that develops wearable medical technology and point-of-care tests to help patients and physicians manage chronic pain, nerve...

April 16, 2014

CINCINNATI--(BUSINESS WIRE)--BioRx introduces outcomes reporting program for primary immune deficiency disease.

April 16, 2014

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Proteus Digital HealthTM, a leading digital medicines company, today announced the expansion of the company’s executive team and board of directors with the addition of three industry leaders across consumer...

April 16, 2014

HOLLISTON, Mass.--(BUSINESS WIRE)--Harvard Apparatus Regenerative Technology, Inc. (NASDAQ:HART), a clinical stage biotechnology company developing regenerated organs for transplant, initially focused on the trachea, has hired Saverio La...